Related Experiment Video
Updated: May 14, 2026

A Hepatocellular Cancer Patient-Derived Organoid Xenograft Model to Investigate Impact of Liver Regeneration on Tumor Growth
Published on: February 2, 2024
GRK6 expression in patients with hepatocellular carcinoma
1Department of Infectious Disease, Huanggang Center Hospital, Huanggang 438000, China. jzlypl@163.com
G protein-coupled receptor kinase 6 (GRK6) is overexpressed in hepatocellular carcinoma (HCC). GRK6 may serve as a biomarker for early diagnosis and prognosis in HCC patients.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern.
- The role of specific kinases in HCC progression requires further elucidation.
Purpose of the Study:
- To investigate the expression levels of G protein-coupled receptor kinase 6 (GRK6) in HCC.
- To explore the potential roles and clinical significance of GRK6 in HCC pathogenesis.
Main Methods:
- Utilized immunohistochemistry and Western blot techniques.
- Analyzed GRK6 expression in 73 HCC tissue samples and matched normal hepatic tissues.
- Correlated GRK6 expression with various clinicopathological features.
Main Results:
- GRK6 expression was significantly elevated in HCC tissues compared to normal hepatic tissues.
- GRK6 expression showed a positive correlation with the proliferation marker Ki-67.
- GRK6 levels were associated with advanced clinical stage, metastasis, and patient survival time.
Conclusions:
- GRK6 overexpression is implicated in the development and progression of HCC.
- GRK6 may function as a potential biomarker for early diagnosis and prognosis assessment in HCC.
More Related Videos
09:13Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2
Published on: October 24, 2016
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013